Ensuring Informed CML Care from Diagnosis Onward
Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following:
- As patients progress through their CML journey, how does the focus of shared decision-making evolve between the patient, caregiver, and healthcare team? What are some of the key challenges or changes you've observed in the patient, physician, and caregiver role over time?
- What advice would you direct to patients and caregivers in navigating these changes?
Recent Videos
Related Content
